Literature DB >> 12023288

Membrane localization and topology of leukotriene C4 synthase.

Peter Christmas1, Brittany M Weber, Mary McKee, Dennis Brown, Roy J Soberman.   

Abstract

Leukotriene C(4) (LTC(4)) synthase conjugates LTA(4) with GSH to form LTC(4). Determining the site of LTC(4) synthesis and the topology of LTC(4) synthase may uncover unappreciated intracellular roles for LTC(4), as well as how LTC(4) is transferred to its export carrier, the multidrug resistance protein-1. We have determined the membrane localization of LTC(4) synthase by immunoelectron microscopy. In contrast to the closely related five-lipoxygenase-activating protein, LTC(4) synthase is distributed in the outer nuclear membrane and peripheral endoplasmic reticulum but is excluded from the inner nuclear membrane. We have combined immunofluorescence with differential membrane permeabilization to determine the topology of LTC(4) synthase. The active site of LTC(4) synthase is localized in the lumen of the nuclear envelope and endoplasmic reticulum. These results indicate that the synthesis of LTB(4) and LTC(4) occurs in different subcellular locations and suggests that LTC(4) must be returned to the cytoplasmic side of the membrane for export by multidrug resistance protein-1. The differential localization of two very similar integral membrane proteins suggests that mechanisms other than size-dependent exclusion regulate their passage to the inner nuclear membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023288     DOI: 10.1074/jbc.M203074200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  The membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Jesse Skoch; Brian J Bacskai; Bradley T Hyman; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Shihua Xu; Douglas Wisniewski; Jilly F Evans; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

Review 3.  Location, location, location: compartmentalization of early events in leukotriene biosynthesis.

Authors:  Marcia E Newcomer; Nathaniel C Gilbert
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

4.  Leukotriene Inhibitors in Sinusitis.

Authors:  John W Steinke; Joshua L Kennedy
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

5.  Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells.

Authors:  S Brandon Early; Elizabeth Barekzi; Julie Negri; Kathleen Hise; Larry Borish; John W Steinke
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

Review 6.  Vertebrate membrane proteins: structure, function, and insights from biophysical approaches.

Authors:  Daniel J Müller; Nan Wu; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2008-03-05       Impact factor: 25.468

Review 7.  Localization and function of cytosolic phospholipase A2alpha at the Golgi.

Authors:  Christina C Leslie; Todd A Gangelhoff; Michael H Gelb
Journal:  Biochimie       Date:  2010-03-10       Impact factor: 4.079

Review 8.  Leukotriene synthesis inhibitors versus antagonists: the pros and cons.

Authors:  John W Steinke; Jeffrey A Culp
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

9.  The nuclear membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Phillip B Jones; Angela M Bair; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Douglas Wisniewski; John Menke; Jilly F Evans; Bradley T Hyman; Brian Bacskai; Mei Chen; David M Lee; Boris Nikolic; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 10.  Leukotriene biosynthetic enzymes as therapeutic targets.

Authors:  Jesper Z Haeggström
Journal:  J Clin Invest       Date:  2018-07-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.